Business Model
- Game changer for unmet medical need.
- Science validated across multiple in vitro and in vivo models.
- Advanced from feasibility tests to drug development.
- Extensive world-wide patent portfolio.
- Pipeline of products in development.
- Ability to obtain non-dilutive funding.
- Ability to attract equity investment.
- Clearly defined regulatory process.
Technology
Allander focuses on cell-penetrating biologics
